367 related articles for article (PubMed ID: 33576905)
21. Possible role of purinergic signaling in COVID-19.
Franciosi MLM; Lima MDM; Schetinger MRC; Cardoso AM
Mol Cell Biochem; 2021 Aug; 476(8):2891-2898. PubMed ID: 33740184
[TBL] [Abstract][Full Text] [Related]
22. Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs.
Feliu C; Peyret H; Poitevin G; Cazaubon Y; Oszust F; Nguyen P; Millart H; Djerada Z
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909368
[TBL] [Abstract][Full Text] [Related]
23. Purinergic Signaling in Endometriosis-Associated Pain.
Trapero C; Martín-Satué M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198179
[TBL] [Abstract][Full Text] [Related]
24. Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease.
Künzli BM; Berberat PO; Giese T; Csizmadia E; Kaczmarek E; Baker C; Halaceli I; Büchler MW; Friess H; Robson SC
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G223-30. PubMed ID: 16920697
[TBL] [Abstract][Full Text] [Related]
25. Purinergic contribution to amyotrophic lateral sclerosis.
Volonté C; Apolloni S; Parisi C; Amadio S
Neuropharmacology; 2016 May; 104():180-93. PubMed ID: 26514402
[TBL] [Abstract][Full Text] [Related]
26. Unveiling the Potential of Purinergic Signaling in Schistosomiasis Treatment.
Oliveira NF; Silva CLM
Curr Top Med Chem; 2021; 21(3):193-204. PubMed ID: 32972342
[TBL] [Abstract][Full Text] [Related]
27. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
28. Role of purinergic receptors in the Alzheimer's disease.
Cieślak M; Wojtczak A
Purinergic Signal; 2018 Dec; 14(4):331-344. PubMed ID: 30362042
[TBL] [Abstract][Full Text] [Related]
29. Extracellular purines, purinergic receptors and tumor growth.
Di Virgilio F; Adinolfi E
Oncogene; 2017 Jan; 36(3):293-303. PubMed ID: 27321181
[TBL] [Abstract][Full Text] [Related]
30. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
31. Impact of ectoenzymes on p2 and p1 receptor signaling.
Kukulski F; Lévesque SA; Sévigny J
Adv Pharmacol; 2011; 61():263-99. PubMed ID: 21586362
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation.
Ma X; Pan X; Wei Y; Tan B; Yang L; Ren H; Qian M; Du B
Oncotarget; 2016 May; 7(20):29036-50. PubMed ID: 27074554
[TBL] [Abstract][Full Text] [Related]
33. A Purinergic Trail for Metastases.
Ferrari D; Malavasi F; Antonioli L
Trends Pharmacol Sci; 2017 Mar; 38(3):277-290. PubMed ID: 27989503
[TBL] [Abstract][Full Text] [Related]
34. Adenosine arrests breast cancer cell motility by A3 receptor stimulation.
Ledderose C; Hefti MM; Chen Y; Bao Y; Seier T; Li L; Woehrle T; Zhang J; Junger WG
Purinergic Signal; 2016 Dec; 12(4):673-685. PubMed ID: 27577957
[TBL] [Abstract][Full Text] [Related]
35. Multifaceted Effects of Extracellular Adenosine Triphosphate and Adenosine in the Tumor-Host Interaction and Therapeutic Perspectives.
de Andrade Mello P; Coutinho-Silva R; Savio LEB
Front Immunol; 2017; 8():1526. PubMed ID: 29184552
[TBL] [Abstract][Full Text] [Related]
36. P2X7 receptor: a critical regulator and potential target for breast cancer.
Zhu X; Li Q; Song W; Peng X; Zhao R
J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
[TBL] [Abstract][Full Text] [Related]
37. Unlocking the Potential of Purinergic Signaling in Transplantation.
Zeiser R; Robson SC; Vaikunthanathan T; Dworak M; Burnstock G
Am J Transplant; 2016 Oct; 16(10):2781-2794. PubMed ID: 27005321
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Ca2+ signaling and glucagon secretion in mouse pancreatic alpha-cells by extracellular ATP and purinergic receptors.
Tudurí E; Filiputti E; Carneiro EM; Quesada I
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E952-60. PubMed ID: 18349114
[TBL] [Abstract][Full Text] [Related]
39. Intestinal ischemia-reperfusion injury alters purinergic receptor expression in clinically relevant extraintestinal organs.
Milano PM; Douillet CD; Riesenman PJ; Robinson WP; Beidler SK; Zarzaur BL; Rich PB
J Surg Res; 2008 Apr; 145(2):272-8. PubMed ID: 17688885
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective role of resveratrol mediated by purinergic signalling in cerebral cortex of mice infected by Toxoplasma gondii.
Bottari NB; Reichert KP; Fracasso M; Dutra A; Assmann CE; Ulrich H; Schetinger MRC; Morsch VM; Da Silva AS
Parasitol Res; 2020 Sep; 119(9):2897-2905. PubMed ID: 32677001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]